Article

Allogeneic CAR-T Therapy Technologies: Has the Promise Been Met?

2023-12-01

Abstract excerpt

This last decade, chimeric antigen receptor (CAR) T-cell therapy has become a real treatment option for patients with B-cell malignancies, while multiple efforts are being made to extend this therapy to other malignancies and broader patient populations. However, several limitations remain, including those associated with the time-consuming and highly personalized manufacturing of autologous CAR-Ts. Technologies t...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 775e480d-85b7-5109-9273-2942b8c4a7ec
DOI: 10.20944/preprints202311.2011.v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Allogeneic CAR-T Therapy Technologies: Has the Promise Been Met?DOI 10.20944/preprints202311.2011.v1Read

Engineering strategies to safely drive CAR T-cells into the futureSemantic proximity Read

Use of Cell and Genome Modification Technologies to Generate Improved “Off-the-Shelf” CAR T and CAR NK CellsSemantic proximity Read

Progress and pitfalls of gene editing technology in CAR-T cell therapy: a state-of-the-art reviewSemantic proximity Read

Toward “off‐the‐shelf” allogeneic CAR T cellsSemantic proximity Read

Genome-edited allogeneic donor “universal” chimeric antigen receptor T cellsSemantic proximity Read

Allogeneic CAR-T Cells: Engineering Around Host ImmunitySemantic proximity Read

A differentiated and durable allogeneic strategy applicable to cell therapiesSemantic proximity Read

Advances in Allogeneic Cancer Cell Therapy and Future Perspectives on “Off-the-Shelf” T Cell Therapy Using iPSC Technology and Gene EditingSemantic proximity Read

Advancing cell-based cancer immunotherapy through stem cell engineeringSemantic proximity Read

Genome Editing in Engineered T Cells for Cancer ImmunotherapySemantic proximity Read

RNA Therapeutics for Improving CAR T-cell Safety and EfficacySemantic proximity Read

Engineering the next generation of allogeneic CAR cells: iPSCs as a scalable and editable platformSemantic proximity Read